Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous esomeprazole after endoscopic hemostasis for peptic ulcer bleeding
2005-002441-39Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Peptic ulcer disease (PUD) comparing Esomeprazole infusion with Placebo infusion (2 arms). Started Jun 2005; status: completed.
02
Drugs
esomeprazole
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on 2005-002441-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002441-39.